Neogenomics Inc
NEO· Nasdaq
NEONeogenomics Inc
Filed Feb 25, 2021 · 10-K · 56 days after period end · 0001077183-21-000064
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019 | Q4 2018 | Q4 2017 |
|---|---|---|---|---|
| Revenue | $126.00M | $106.87M | $76.48M | $61.42M |
| Net Income | $15.42M | $6.30M | $353.00K | $4.55M |
| EPS Diluted | — | $0.06 | $0.00 | $0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Feb 25, 2021 · 56 d after period end
